Accenture, today announced it is acquiring Enterprise System Partners (ESP), an Ireland-based consulting and manufacturing services provider for the life sciences industry. As part of the acquisition, ESP will join Accenture Industry X.0, which helps clients master the digital reinvention of industry, strengthening Accenture’s capabilities to transform manufacturing for pharmaceutical, biotech and medical device clients globally.
The combination of ESP’s digitally-enabled manufacturing services and Accenture’s Industry X.0 capabilities will allow clients to take advantage of engineering and product lifecycle management, advanced analytics and artificial intelligence for a more flexible, efficient and cost-effective production process. The acquisition will complement others that Accenture has made in recent years, including the 2017 acquisition of LabAnswer, now Accenture Scientific Informatics Services (ASIS), which helps capture, manage, and analyze complex laboratory and scientific data.
Founded in 2003, ESP has long-standing industry experience in planning and implementing manufacturing solutions, with niche expertise in manufacturing execution systems (MES) and serialization. MES digitally track and document the production process, providing the groundwork for more automated and analytics-driven manufacturing and supply chains. Serialization allows life science companies to digitally track each saleable unit from the packaging line all the way to the patient.
ESP currently services 17 of the top 20 global pharmaceutical and biotech companies from offices in Ireland, France, the Netherlands, Puerto Rico, Turkey, and the United States. Their team of 200 professionals with deep manufacturing, process and IT knowledge will work closely with Accenture’s Life Sciences group to support pharmaceutical, biotech, and medical device clients.
Financial details of the acquisition were not disclosed.
